Summit Global Investments’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-59,577
| Closed | -$2.55M | – | 532 |
|
|
2024
Q1 | $2.55M | Buy |
59,577
+20,195
| +51% | +$866K | 0.19% | 98 |
|
|
2023
Q4 | $1.46M | Sell |
39,382
-44
| -0.1% | -$1.63K | 0.1% | 168 |
|
|
2023
Q3 | $1.43M | Sell |
39,426
-359
| -0.9% | -$13K | 0.1% | 160 |
|
|
2023
Q2 | $1.42M | Buy |
39,785
+10,525
| +36% | +$375K | 0.09% | 168 |
|
|
2023
Q1 | $1.04M | Buy |
+29,260
| New | +$1.04M | 0.08% | 228 |
|
|
2022
Q3 | – | Sell |
-25,169
| Closed | -$1.37M | – | 474 |
|
|
2022
Q2 | $1.37M | Sell |
25,169
-89
| -0.4% | -$4.84K | 0.12% | 176 |
|
|
2022
Q1 | $1.38M | Sell |
25,258
-784
| -3% | -$42.7K | 0.1% | 187 |
|
|
2021
Q4 | $1.44M | Buy |
26,042
+2,171
| +9% | +$120K | 0.09% | 193 |
|
|
2021
Q3 | $1.14M | Buy |
23,871
+1,236
| +5% | +$59K | 0.09% | 188 |
|
|
2021
Q2 | $1.13M | Sell |
22,635
-551
| -2% | -$27.4K | 0.07% | 214 |
|
|
2021
Q1 | $1.03M | Buy |
23,186
+1,784
| +8% | +$79.6K | 0.07% | 192 |
|
|
2020
Q4 | $984K | Buy |
21,402
+4,670
| +28% | +$215K | 0.1% | 154 |
|
|
2020
Q3 | $787K | Buy |
16,732
+238
| +1% | +$11.2K | 0.08% | 156 |
|
|
2020
Q2 | $841K | Buy |
16,494
+3,752
| +29% | +$191K | 0.1% | 139 |
|
|
2020
Q1 | $603K | Sell |
12,742
-2,254
| -15% | -$107K | 0.09% | 150 |
|
|
2019
Q4 | $881K | Buy |
14,996
+1,224
| +9% | +$71.9K | 0.1% | 166 |
|
|
2019
Q3 | $735K | Buy |
13,772
+188
| +1% | +$10K | 0.09% | 230 |
|
|
2019
Q2 | $680K | Buy |
+13,584
| New | +$680K | 0.09% | 224 |
|
|
2017
Q4 | – | Sell |
-10,200
| Closed | -$518K | – | 264 |
|
|
2017
Q3 | $518K | Sell |
10,200
-1,496
| -13% | -$76K | 0.08% | 177 |
|
|
2017
Q2 | $630K | Buy |
11,696
+1,736
| +17% | +$93.5K | 0.19% | 100 |
|
|
2017
Q1 | $525K | Buy |
+9,960
| New | +$525K | 0.17% | 109 |
|